By Baylor College of Medicine –
Novel therapeutic approaches are needed for children with diffuse midline glioma (DMG) and other recurrent high-grade central nervous system (CNS) tumors, aggressive brain cancers with poor prognoses. A type of immunotherapy using T cells modified with chimeric antigen receptors (CAR T) has demonstrated efficacy in other cancers, but use in DMG and other CNS tumors has been limited.
:max_bytes(150000):strip_icc():format(webp)/Blood-In-Lab-GettyImages-73329514-8f6d6e24438049eab4fb5bd13d59954c.jpg "CAR T-Cell Therapy Helps Lupus Patients Enter Remission In Small Study")
